Fig. 3From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinibRelationship between triglyceride, total cholesterol, low density lipoprotein, and high density lipoprotein with overall survival rates (PA = 0.084, PB = 0.003, PC = 0.029, PD = 0.622)Back to article page